Bosnia and Herzegovina vs Kiribati: The number of people with susceptibility test result for rifampicin
Bosnia and Herzegovina
97.7
in 2021
Kiribati
96.72
in 2021
Bosnia and Herzegovina rank
38th
Kiribati rank
41st
The number of people with susceptibility test result for rifampicin over time
- Bosnia and Herzegovina
- Kiribati
How they compare
Bosnia and Herzegovina currently reports 97.7 against 96.72 in Kiribati, a difference of 0.98.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Bosnia and Herzegovina ahead.
Bosnia and Herzegovina ranks 38th and Kiribati ranks 41st of 146 countries.
Bosnia and Herzegovina has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | Kiribati | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 93.68 | 66.85 | 26.83 | Bosnia and Herzegovina |
| 2020s | 97.68 | 93.91 | 3.77 | Bosnia and Herzegovina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bosnia and Herzegovina or Kiribati?
- Bosnia and Herzegovina, at 97.7 against 96.72 in Kiribati as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bosnia and Herzegovina and Kiribati?
- 0.98, with Bosnia and Herzegovina ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Kiribati?
- 5 years are reported by both, from 2017 to 2021.
- How do Bosnia and Herzegovina and Kiribati rank globally for the number of people with susceptibility test result for rifampicin?
- Bosnia and Herzegovina ranks 38th and Kiribati ranks 41st of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.